{"id":"https://openalex.org/W4393086489","doi":"https://doi.org/10.1158/1538-7445.am2024-5948","title":"Abstract 5948: FMC-376 a dual inhibitor of ON and OFF states of KRASG12C is broadly active in PDX models of resistance","display_name":"Abstract 5948: FMC-376 a dual inhibitor of ON and OFF states of KRASG12C is broadly active in PDX models of resistance","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393086489","doi":"https://doi.org/10.1158/1538-7445.am2024-5948"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-5948","doi":"https://doi.org/10.1158/1538-7445.am2024-5948","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5948","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100322872","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0003-0671-7312","observed_orcids":["https://orcid.org/0000-0003-0671-7312","https://orcid.org/0000-0003-3934-9835","https://orcid.org/0009-0002-2442-7992","https://orcid.org/0000-0002-0379-9386"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":["1Frontier Medicines, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frontier Medicines, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012792113","display_name":"Richard M. Neve","orcid":"https://orcid.org/0000-0002-7557-5306","observed_orcids":["https://orcid.org/0000-0002-7557-5306"]},"institutions":[{"id":"https://openalex.org/I4387154503","display_name":"Frontier Medicines (United States)","ror":"https://ror.org/01xxhz462","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154503"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Neve","raw_affiliation_strings":["2Frontier Medicines, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frontier Medicines, South San Francisco, CA","institution_ids":["https://openalex.org/I4387154503"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051502319","display_name":"Jocelyn Staunton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154503","display_name":"Frontier Medicines (United States)","ror":"https://ror.org/01xxhz462","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154503"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jocelyn Staunton","raw_affiliation_strings":["2Frontier Medicines, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frontier Medicines, South San Francisco, CA","institution_ids":["https://openalex.org/I4387154503"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075615241","display_name":"Kevin R. Webster","orcid":"https://orcid.org/0000-0002-6776-9055","observed_orcids":["https://orcid.org/0000-0002-6776-9055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin R. Webster","raw_affiliation_strings":["1Frontier Medicines, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Frontier Medicines, Boston, MA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"5948","last_page":"5948"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.05299999937415123,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8930000066757202},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.8690000176429749},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9340000152587891},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/irreversible-covalent-inhibitors","display_name":"irreversible covalent inhibitors","score":0.6399999856948853},{"id":"https://openalex.org/keywords/chemoproteomics","display_name":"chemoproteomics","score":0.7070000171661377},{"id":"https://openalex.org/keywords/fragment-based-drug-discovery","display_name":"fragment-based drug discovery","score":0.8119999766349792},{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.6079999804496765},{"id":"https://openalex.org/keywords/keap1-mutation","display_name":"KEAP1 mutation","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.5244888663291931},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.4855651557445526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3955511450767517},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18325164914131165},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.07163599133491516},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-5948","doi":"https://doi.org/10.1158/1538-7445.am2024-5948","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5948","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415449772","https://openalex.org/W4393086544","https://openalex.org/W4362543843","https://openalex.org/W4399737131","https://openalex.org/W4282971798","https://openalex.org/W4393093339","https://openalex.org/W3181602654","https://openalex.org/W4415701829","https://openalex.org/W4385228183","https://openalex.org/W4402036991"],"abstract_inverted_index":{"Abstract":[0],"KRASG12C":[1,103,143,152,206,234,244,299,321,347,360,373,397],"is":[2,87,90,136,398],"a":[3,77,91,137,168,297,331,350,388],"frequent":[4],"activating":[5,226],"mutation":[6,278],"occurring":[7],"in":[8,69,151,183,185,401],"NSCLC,":[9,307],"CRC,":[10],"PDAC":[11],"and":[12,63,84,99,110,130,153,158,235,289,309,319,326,337,357,370,393],"other":[13],"tumors":[14,329],"that":[15,39,144,198,213,238,265,313],"shifts":[16],"KRAS":[17,24,164,253,270],"into":[18,178],"the":[19,30,41,97,105,120,123,148,156,162,202,362,410],"active,":[20],"GTP-bound":[21],"(ON)":[22],"state.":[23],"was":[25,117],"long":[26],"considered":[27],"undruggable":[28],"until":[29],"recent":[31],"discovery":[32],"of":[33,46,52,61,79,95,102,114,122,142,161,172,205,216,223,228,233,243,248,269,279,294,306,316,328,334,341,355,367,391,396,404,409],"single":[34,368],"acting":[35,369],"inhibitors,":[36],"including":[37],"those":[38],"bind":[40,201],"GDP-bound,":[42],"inactive":[43],"(OFF),":[44],"state":[45,189,204,218,346,359,372],"KRASG12C.":[47,219],"The":[48],"most":[49],"clinically":[50],"advanced":[51],"these":[53],"first-generation":[54,196],"molecules":[55],"have":[56],"demonstrated":[57,312],"clinical":[58,342,351],"response":[59],"rates":[60],"37-43%":[62],"6":[64],"to":[65,107,147,167,187,195,240,246,257,323,344,364],"7-month":[66],"progression-free":[67],"survival":[68],"lung":[70],"cancer":[71],"patients.":[72],"While":[73],"an":[74],"important":[75],"advance,":[76],"majority":[78],"cancers":[80],"do":[81],"not":[82],"respond,":[83],"acquired":[85],"resistance":[86,109,194,224,343,405],"common.":[88],"FMC-376":[89,116,135,295,349,387],"next-generation":[92],"dual":[93,314,353,389],"inhibitor":[94,141,354,390],"both":[96,317],"ON":[98,157,217,318,356,392],"OFF":[100,159,188,203,320,345,358,371,394],"states":[101,160,395],"with":[104,210,274],"potential":[106,363],"overcome":[108,365],"deliver":[111],"best-in-class":[112],"durability":[113],"response.":[115],"discovered":[118],"through":[119],"application":[121],"FrontierTM":[124],"platform,":[125],"which":[126],"integrates":[127],"chemoproteomics,":[128],"machine-learning,":[129],"covalent":[131],"fragment-based":[132],"drug":[133],"discovery.":[134],"highly":[138],"selective,":[139],"irreversible":[140],"covalently":[145],"binds":[146],"mutant":[149,163,300],"cysteine":[150],"directly":[154],"blocks":[155],"protein":[165],"leading":[166],"complete,":[169],"durable":[170,180],"blockade":[171],"downstream":[173],"signaling.":[174],"This":[175],"further":[176],"translates":[177],"more":[179],"tumor":[181],"regressions":[182],"vivo":[184,292],"comparison":[186],"inhibitors":[190,197],"like":[191],"sotorasib.":[192],"Clinical":[193],"can":[199],"only":[200],"has":[207,311,361],"been":[208],"associated":[209,273],"multiple":[211,263],"mechanisms":[212,237],"drive":[214],"upregulation":[215],"These":[220,276],"known":[221,335],"drivers":[222,340],"include":[225,277],"co-mutation/amplification/fusions":[227],"receptor":[229],"tyrosine":[230],"kinases,":[231],"amplification":[232],"non-mutational":[236],"lead":[239],"paradoxical":[241],"activation":[242],"due":[245],"release":[247],"negative":[249],"feedback":[250],"control":[251],"upon":[252],"inhibition,":[254],"often":[255],"referred":[256],"as":[258],"adaptive":[259],"resistance.":[260,275],"In":[261,291],"addition,":[262],"mutations":[264],"may":[266],"act":[267],"independently":[268],"are":[271],"also":[272],"KEAP1,":[280],"CDKN2A,":[281],"SMARCA4,":[282],"PI3K,":[283],"PTEN,":[284],"MTOR,":[285],"HRAS,":[286],"NRAS,":[287],"RAF,":[288],"MAPK.":[290],"profiling":[293],"against":[296],"panel":[298],"patient":[301],"derived":[302],"xenograft":[303],"(PDX)":[304],"models":[305,403],"CRC":[308],"PDAC,":[310],"inhibition":[315],"leads":[322],"complete":[324],"suppression":[325],"regression":[327],"carrying":[330],"broad":[332],"spectrum":[333],"genomic":[336],"non-genomic":[338],"(adaptive)":[339],"inhibitors.":[348,374],"stage":[352],"limitations":[366],"Citation":[375],"Format:":[376],"Yan":[377],"Wang,":[378],"Richard":[379],"M.":[380],"Neve,":[381],"Jocelyn":[382],"Staunton,":[383],"Kevin":[384],"R.":[385],"Webster.":[386],"broadly":[399],"active":[400],"PDX":[402],"[abstract].":[406],"In:":[407],"Proceedings":[408],"American":[411],"Association":[412],"for":[413],"Cancer":[414,432],"Research":[415],"Annual":[416],"Meeting":[417],"2024;":[418],"Part":[419],"1":[420],"(Regular":[421],"Abstracts);":[422],"2024":[423],"Apr":[424],"5-10;":[425],"San":[426],"Diego,":[427],"CA.":[428],"Philadelphia":[429],"(PA):":[430],"AACR;":[431],"Res":[433],"2024;84(6_Suppl):Abstract":[434],"nr":[435],"5948.":[436]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-03-23T00:00:00"}